nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—Cytochrome P450 2D6 Inhibitors—Quinidine—malaria	0.53	1	CiPCiCtD
Pazopanib—KDR—malaria	0.179	1	CbGaD
Pazopanib—SLCO1B1—Quinidine—malaria	0.0141	0.0868	CbGbCtD
Pazopanib—CYP2C8—Sulfadiazine—malaria	0.0132	0.0811	CbGbCtD
Pazopanib—CYP2C8—Pyrimethamine—malaria	0.0132	0.0811	CbGbCtD
Pazopanib—CYP3A4—Clindamycin—malaria	0.00931	0.0573	CbGbCtD
Pazopanib—CYP2D6—Pyrimethamine—malaria	0.00841	0.0517	CbGbCtD
Pazopanib—CYP1A2—Proguanil—malaria	0.00816	0.0502	CbGbCtD
Pazopanib—CYP2D6—Artemether—malaria	0.00715	0.044	CbGbCtD
Pazopanib—CYP2C8—Quinine—malaria	0.0068	0.0418	CbGbCtD
Pazopanib—CYP2D6—Proguanil—malaria	0.00673	0.0414	CbGbCtD
Pazopanib—CYP2D6—Quinidine barbiturate—malaria	0.00638	0.0392	CbGbCtD
Pazopanib—CYP2C8—Quinidine—malaria	0.00597	0.0367	CbGbCtD
Pazopanib—CYP1A2—Pentoxifylline—malaria	0.00586	0.0361	CbGbCtD
Pazopanib—CYP3A4—Sulfadiazine—malaria	0.00535	0.0329	CbGbCtD
Pazopanib—CYP1A2—Quinine—malaria	0.00526	0.0323	CbGbCtD
Pazopanib—CYP2C8—Dapsone—malaria	0.00515	0.0317	CbGbCtD
Pazopanib—CYP1A2—Quinidine—malaria	0.00462	0.0284	CbGbCtD
Pazopanib—ABCB1—Quinine—malaria	0.0046	0.0283	CbGbCtD
Pazopanib—CYP3A4—Artemether—malaria	0.00455	0.028	CbGbCtD
Pazopanib—CYP2D6—Quinine—malaria	0.00433	0.0267	CbGbCtD
Pazopanib—CYP3A4—Proguanil—malaria	0.00428	0.0263	CbGbCtD
Pazopanib—CYP3A4—Doxycycline—malaria	0.00405	0.0249	CbGbCtD
Pazopanib—ABCB1—Quinidine—malaria	0.00404	0.0249	CbGbCtD
Pazopanib—CYP2D6—Quinidine—malaria	0.00381	0.0234	CbGbCtD
Pazopanib—CYP3A4—Quinine—malaria	0.00276	0.0169	CbGbCtD
Pazopanib—CYP3A4—Quinidine—malaria	0.00242	0.0149	CbGbCtD
Pazopanib—CYP3A4—Dapsone—malaria	0.00209	0.0128	CbGbCtD
Pazopanib—TAOK1—blood plasma—malaria	0.00101	0.0216	CbGeAlD
Pazopanib—LYN—blood plasma—malaria	0.000799	0.0171	CbGeAlD
Pazopanib—FLT4—endothelium—malaria	0.000698	0.015	CbGeAlD
Pazopanib—FGF1—endothelium—malaria	0.00062	0.0133	CbGeAlD
Pazopanib—ITK—hematopoietic system—malaria	0.000613	0.0131	CbGeAlD
Pazopanib—MAP3K2—blood plasma—malaria	0.000585	0.0125	CbGeAlD
Pazopanib—TAOK1—hematopoietic system—malaria	0.000558	0.012	CbGeAlD
Pazopanib—FGF1—blood plasma—malaria	0.000551	0.0118	CbGeAlD
Pazopanib—FLT1—endothelium—malaria	0.000543	0.0116	CbGeAlD
Pazopanib—SH2B3—hematopoietic system—malaria	0.000525	0.0113	CbGeAlD
Pazopanib—MAP3K9—digestive system—malaria	0.000517	0.0111	CbGeAlD
Pazopanib—FLT1—blood plasma—malaria	0.000482	0.0103	CbGeAlD
Pazopanib—PLK4—hematopoietic system—malaria	0.000473	0.0101	CbGeAlD
Pazopanib—KDR—endothelium—malaria	0.000459	0.00985	CbGeAlD
Pazopanib—STK10—blood plasma—malaria	0.000456	0.00979	CbGeAlD
Pazopanib—TAOK3—blood plasma—malaria	0.000455	0.00975	CbGeAlD
Pazopanib—STK16—hematopoietic system—malaria	0.000446	0.00958	CbGeAlD
Pazopanib—LYN—hematopoietic system—malaria	0.000442	0.00948	CbGeAlD
Pazopanib—FGFR3—hematopoietic system—malaria	0.000439	0.00943	CbGeAlD
Pazopanib—UGT1A1—blood plasma—malaria	0.000431	0.00925	CbGeAlD
Pazopanib—KDR—blood plasma—malaria	0.000408	0.00874	CbGeAlD
Pazopanib—PI4KB—saliva-secreting gland—malaria	0.000407	0.00874	CbGeAlD
Pazopanib—KIT—endothelium—malaria	0.000407	0.00873	CbGeAlD
Pazopanib—ITK—blood—malaria	0.000406	0.00871	CbGeAlD
Pazopanib—CSF1R—blood plasma—malaria	0.000398	0.00853	CbGeAlD
Pazopanib—ITK—bone marrow—malaria	0.000393	0.00842	CbGeAlD
Pazopanib—MAP3K9—liver—malaria	0.000385	0.00826	CbGeAlD
Pazopanib—LIMK2—hematopoietic system—malaria	0.000382	0.00819	CbGeAlD
Pazopanib—TAOK1—blood—malaria	0.000369	0.00793	CbGeAlD
Pazopanib—KIT—blood plasma—malaria	0.000361	0.00775	CbGeAlD
Pazopanib—FGFR3—kidney—malaria	0.00036	0.00773	CbGeAlD
Pazopanib—SLCO1B1—blood plasma—malaria	0.000359	0.00769	CbGeAlD
Pazopanib—TAOK1—bone marrow—malaria	0.000357	0.00767	CbGeAlD
Pazopanib—PIP4K2C—saliva-secreting gland—malaria	0.000357	0.00767	CbGeAlD
Pazopanib—SH2B3—blood—malaria	0.000348	0.00746	CbGeAlD
Pazopanib—FLT4—hematopoietic system—malaria	0.000343	0.00736	CbGeAlD
Pazopanib—SH2B3—bone marrow—malaria	0.000337	0.00722	CbGeAlD
Pazopanib—MAP3K2—hematopoietic system—malaria	0.000323	0.00694	CbGeAlD
Pazopanib—PI4KB—kidney—malaria	0.000319	0.00683	CbGeAlD
Pazopanib—PLK4—blood—malaria	0.000313	0.00672	CbGeAlD
Pazopanib—STK16—digestive system—malaria	0.00031	0.00666	CbGeAlD
Pazopanib—MAP3K9—brain—malaria	0.000305	0.00655	CbGeAlD
Pazopanib—FGF1—hematopoietic system—malaria	0.000305	0.00653	CbGeAlD
Pazopanib—PLK4—bone marrow—malaria	0.000303	0.0065	CbGeAlD
Pazopanib—FGFR2—saliva-secreting gland—malaria	0.000301	0.00647	CbGeAlD
Pazopanib—STK16—blood—malaria	0.000296	0.00634	CbGeAlD
Pazopanib—LYN—blood—malaria	0.000293	0.00628	CbGeAlD
Pazopanib—RIOK2—blood—malaria	0.000291	0.00625	CbGeAlD
Pazopanib—TAOK1—liver—malaria	0.000289	0.0062	CbGeAlD
Pazopanib—FGFR2—hematopoietic system—malaria	0.000288	0.00617	CbGeAlD
Pazopanib—RIOK2—bone marrow—malaria	0.000282	0.00604	CbGeAlD
Pazopanib—FLT1—saliva-secreting gland—malaria	0.000279	0.00599	CbGeAlD
Pazopanib—EPHB6—saliva-secreting gland—malaria	0.000276	0.00592	CbGeAlD
Pazopanib—SH2B3—liver—malaria	0.000272	0.00583	CbGeAlD
Pazopanib—FLT1—hematopoietic system—malaria	0.000267	0.00572	CbGeAlD
Pazopanib—TAOK3—saliva-secreting gland—malaria	0.000263	0.00565	CbGeAlD
Pazopanib—STK36—blood—malaria	0.000262	0.00561	CbGeAlD
Pazopanib—PI4KB—blood—malaria	0.000258	0.00552	CbGeAlD
Pazopanib—LIMK2—blood—malaria	0.000253	0.00542	CbGeAlD
Pazopanib—STK10—hematopoietic system—malaria	0.000252	0.00541	CbGeAlD
Pazopanib—TAOK3—hematopoietic system—malaria	0.000251	0.00539	CbGeAlD
Pazopanib—PDGFRA—hematopoietic system—malaria	0.00025	0.00536	CbGeAlD
Pazopanib—FGF1—kidney—malaria	0.00025	0.00536	CbGeAlD
Pazopanib—PI4KB—bone marrow—malaria	0.000249	0.00535	CbGeAlD
Pazopanib—UGT1A1—hematopoietic system—malaria	0.000238	0.00511	CbGeAlD
Pazopanib—KDR—saliva-secreting gland—malaria	0.000236	0.00507	CbGeAlD
Pazopanib—MAP2K5—saliva-secreting gland—malaria	0.000236	0.00507	CbGeAlD
Pazopanib—FGFR2—kidney—malaria	0.000236	0.00506	CbGeAlD
Pazopanib—STK16—liver—malaria	0.000231	0.00496	CbGeAlD
Pazopanib—TAOK1—brain—malaria	0.000229	0.00492	CbGeAlD
Pazopanib—LYN—liver—malaria	0.000229	0.00491	CbGeAlD
Pazopanib—FGFR3—liver—malaria	0.000228	0.00488	CbGeAlD
Pazopanib—RIOK2—liver—malaria	0.000228	0.00488	CbGeAlD
Pazopanib—FLT4—blood—malaria	0.000227	0.00487	CbGeAlD
Pazopanib—PIP4K2C—blood—malaria	0.000226	0.00485	CbGeAlD
Pazopanib—KDR—hematopoietic system—malaria	0.000225	0.00484	CbGeAlD
Pazopanib—CSF1R—hematopoietic system—malaria	0.00022	0.00472	CbGeAlD
Pazopanib—FLT4—bone marrow—malaria	0.00022	0.00472	CbGeAlD
Pazopanib—PIP4K2C—bone marrow—malaria	0.000219	0.00469	CbGeAlD
Pazopanib—FLT1—kidney—malaria	0.000219	0.00469	CbGeAlD
Pazopanib—SH2B3—brain—malaria	0.000216	0.00463	CbGeAlD
Pazopanib—MAP3K2—blood—malaria	0.000214	0.0046	CbGeAlD
Pazopanib—AURKC—brain—malaria	0.000212	0.00456	CbGeAlD
Pazopanib—FGF1—digestive system—malaria	0.000212	0.00454	CbGeAlD
Pazopanib—KIT—saliva-secreting gland—malaria	0.000209	0.00449	CbGeAlD
Pazopanib—MAP3K2—bone marrow—malaria	0.000207	0.00445	CbGeAlD
Pazopanib—STK10—kidney—malaria	0.000207	0.00444	CbGeAlD
Pazopanib—TAOK3—kidney—malaria	0.000206	0.00442	CbGeAlD
Pazopanib—STK36—liver—malaria	0.000205	0.00439	CbGeAlD
Pazopanib—PDGFRB—saliva-secreting gland—malaria	0.000204	0.00439	CbGeAlD
Pazopanib—CYP2C8—blood plasma—malaria	0.000204	0.00438	CbGeAlD
Pazopanib—FGF1—blood—malaria	0.000202	0.00433	CbGeAlD
Pazopanib—PI4KB—liver—malaria	0.000201	0.00432	CbGeAlD
Pazopanib—LCK—blood—malaria	0.000201	0.0043	CbGeAlD
Pazopanib—FGFR2—digestive system—malaria	0.0002	0.00429	CbGeAlD
Pazopanib—KIT—hematopoietic system—malaria	0.0002	0.00428	CbGeAlD
Pazopanib—SLCO1B1—hematopoietic system—malaria	0.000198	0.00425	CbGeAlD
Pazopanib—LIMK2—liver—malaria	0.000198	0.00424	CbGeAlD
Pazopanib—UGT1A1—kidney—malaria	0.000195	0.00419	CbGeAlD
Pazopanib—PDGFRB—hematopoietic system—malaria	0.000195	0.00419	CbGeAlD
Pazopanib—PLK4—brain—malaria	0.000194	0.00417	CbGeAlD
Pazopanib—LCK—bone marrow—malaria	0.000194	0.00416	CbGeAlD
Pazopanib—CYP1A2—blood plasma—malaria	0.000191	0.00409	CbGeAlD
Pazopanib—FGFR2—blood—malaria	0.000191	0.00409	CbGeAlD
Pazopanib—FLT1—digestive system—malaria	0.000185	0.00398	CbGeAlD
Pazopanib—KDR—kidney—malaria	0.000185	0.00396	CbGeAlD
Pazopanib—STK16—brain—malaria	0.000184	0.00394	CbGeAlD
Pazopanib—LYN—brain—malaria	0.000182	0.0039	CbGeAlD
Pazopanib—FGFR3—brain—malaria	0.000181	0.00388	CbGeAlD
Pazopanib—RIOK2—brain—malaria	0.000181	0.00388	CbGeAlD
Pazopanib—MAP3K19—brain—malaria	0.000179	0.00384	CbGeAlD
Pazopanib—BMPR1B—brain—malaria	0.000179	0.00384	CbGeAlD
Pazopanib—FLT4—liver—malaria	0.000178	0.00381	CbGeAlD
Pazopanib—PIP4K2C—liver—malaria	0.000177	0.00379	CbGeAlD
Pazopanib—FLT1—blood—malaria	0.000177	0.00379	CbGeAlD
Pazopanib—STK10—digestive system—malaria	0.000176	0.00377	CbGeAlD
Pazopanib—FGFR1—liver—malaria	0.000175	0.00376	CbGeAlD
Pazopanib—TAOK3—digestive system—malaria	0.000175	0.00375	CbGeAlD
Pazopanib—EPHB6—blood—malaria	0.000175	0.00375	CbGeAlD
Pazopanib—PDGFRA—digestive system—malaria	0.000174	0.00373	CbGeAlD
Pazopanib—MAP3K2—liver—malaria	0.000168	0.00359	CbGeAlD
Pazopanib—STK10—blood—malaria	0.000167	0.00359	CbGeAlD
Pazopanib—TAOK3—blood—malaria	0.000167	0.00357	CbGeAlD
Pazopanib—UGT1A1—digestive system—malaria	0.000166	0.00356	CbGeAlD
Pazopanib—PDGFRA—blood—malaria	0.000166	0.00355	CbGeAlD
Pazopanib—KIT—kidney—malaria	0.000164	0.00351	CbGeAlD
Pazopanib—SLCO1B1—kidney—malaria	0.000163	0.00349	CbGeAlD
Pazopanib—STK36—brain—malaria	0.000162	0.00348	CbGeAlD
Pazopanib—STK10—bone marrow—malaria	0.000162	0.00347	CbGeAlD
Pazopanib—Photosensitivity reaction—Dapsone—malaria	0.000162	0.0033	CcSEcCtD
Pazopanib—TAOK3—bone marrow—malaria	0.000161	0.00346	CbGeAlD
Pazopanib—Gastrointestinal pain—Proguanil—malaria	0.000161	0.00329	CcSEcCtD
Pazopanib—Vomiting—Pyrimethamine—malaria	0.000161	0.00328	CcSEcCtD
Pazopanib—Abdominal pain upper—Quinidine barbiturate—malaria	0.00016	0.00327	CcSEcCtD
Pazopanib—Neutropenia—Clindamycin—malaria	0.00016	0.00327	CcSEcCtD
Pazopanib—PDGFRB—kidney—malaria	0.00016	0.00343	CbGeAlD
Pazopanib—PI4KB—brain—malaria	0.00016	0.00343	CbGeAlD
Pazopanib—Breast disorder—Quinidine barbiturate—malaria	0.000158	0.00324	CcSEcCtD
Pazopanib—UGT1A1—blood—malaria	0.000158	0.00339	CbGeAlD
Pazopanib—FGF1—liver—malaria	0.000158	0.00339	CbGeAlD
Pazopanib—Neutropenia—Quinine—malaria	0.000157	0.00321	CcSEcCtD
Pazopanib—Neutropenia—Quinidine—malaria	0.000157	0.00321	CcSEcCtD
Pazopanib—LIMK2—brain—malaria	0.000157	0.00337	CbGeAlD
Pazopanib—LCK—liver—malaria	0.000157	0.00336	CbGeAlD
Pazopanib—KDR—digestive system—malaria	0.000157	0.00336	CbGeAlD
Pazopanib—Photosensitivity reaction—Clindamycin—malaria	0.000156	0.00319	CcSEcCtD
Pazopanib—Abdominal pain—Proguanil—malaria	0.000156	0.00318	CcSEcCtD
Pazopanib—Photosensitivity reaction—Quinidine—malaria	0.000153	0.00313	CcSEcCtD
Pazopanib—Photosensitivity reaction—Quinine—malaria	0.000153	0.00313	CcSEcCtD
Pazopanib—CSF1R—digestive system—malaria	0.000153	0.00328	CbGeAlD
Pazopanib—Abdominal distension—Pentoxifylline—malaria	0.000152	0.00311	CcSEcCtD
Pazopanib—KDR—blood—malaria	0.000149	0.0032	CbGeAlD
Pazopanib—MAP2K5—blood—malaria	0.000149	0.0032	CbGeAlD
Pazopanib—FGFR2—liver—malaria	0.000149	0.0032	CbGeAlD
Pazopanib—Jaundice—Clindamycin—malaria	0.000149	0.00304	CcSEcCtD
Pazopanib—Jaundice—Quinine—malaria	0.000146	0.00298	CcSEcCtD
Pazopanib—Jaundice—Quinidine—malaria	0.000146	0.00298	CcSEcCtD
Pazopanib—CSF1R—blood—malaria	0.000146	0.00313	CbGeAlD
Pazopanib—KDR—bone marrow—malaria	0.000144	0.0031	CbGeAlD
Pazopanib—Epistaxis—Clindamycin—malaria	0.000144	0.00294	CcSEcCtD
Pazopanib—Leukopenia—Sulfadiazine—malaria	0.000143	0.00293	CcSEcCtD
Pazopanib—Neutropenia—Quinidine barbiturate—malaria	0.000142	0.0029	CcSEcCtD
Pazopanib—CSF1R—bone marrow—malaria	0.000141	0.00303	CbGeAlD
Pazopanib—FLT4—brain—malaria	0.000141	0.00302	CbGeAlD
Pazopanib—PIP4K2C—brain—malaria	0.00014	0.00301	CbGeAlD
Pazopanib—FGFR1—brain—malaria	0.000139	0.00298	CbGeAlD
Pazopanib—KIT—digestive system—malaria	0.000139	0.00298	CbGeAlD
Pazopanib—Photosensitivity reaction—Quinidine barbiturate—malaria	0.000138	0.00283	CcSEcCtD
Pazopanib—CYP3A4—blood plasma—malaria	0.000138	0.00296	CbGeAlD
Pazopanib—FLT1—liver—malaria	0.000138	0.00296	CbGeAlD
Pazopanib—SLCO1B1—digestive system—malaria	0.000138	0.00296	CbGeAlD
Pazopanib—Bradycardia—Quinidine—malaria	0.000137	0.0028	CcSEcCtD
Pazopanib—Bradycardia—Quinine—malaria	0.000137	0.0028	CcSEcCtD
Pazopanib—Arthralgia—Sulfadiazine—malaria	0.000136	0.00279	CcSEcCtD
Pazopanib—CYP2D6—blood plasma—malaria	0.000136	0.00292	CbGeAlD
Pazopanib—PDGFRB—digestive system—malaria	0.000136	0.00291	CbGeAlD
Pazopanib—Haemoglobin—Quinidine—malaria	0.000135	0.00276	CcSEcCtD
Pazopanib—Haemoglobin—Quinine—malaria	0.000135	0.00276	CcSEcCtD
Pazopanib—Infestation NOS—Pentoxifylline—malaria	0.000135	0.00276	CcSEcCtD
Pazopanib—Infestation—Pentoxifylline—malaria	0.000135	0.00276	CcSEcCtD
Pazopanib—Diarrhoea—Proguanil—malaria	0.000135	0.00275	CcSEcCtD
Pazopanib—Haemorrhage—Quinidine—malaria	0.000134	0.00275	CcSEcCtD
Pazopanib—Haemorrhage—Quinine—malaria	0.000134	0.00275	CcSEcCtD
Pazopanib—MAP3K2—brain—malaria	0.000133	0.00285	CbGeAlD
Pazopanib—Urinary tract disorder—Quinidine—malaria	0.000133	0.00271	CcSEcCtD
Pazopanib—Urinary tract disorder—Quinine—malaria	0.000133	0.00271	CcSEcCtD
Pazopanib—KIT—blood—malaria	0.000132	0.00284	CbGeAlD
Pazopanib—Urethral disorder—Quinine—malaria	0.000132	0.00269	CcSEcCtD
Pazopanib—Urethral disorder—Quinidine—malaria	0.000132	0.00269	CcSEcCtD
Pazopanib—Jaundice—Quinidine barbiturate—malaria	0.000132	0.00269	CcSEcCtD
Pazopanib—Jaundice—Pentoxifylline—malaria	0.000131	0.00269	CcSEcCtD
Pazopanib—SLCO1B1—blood—malaria	0.000131	0.00282	CbGeAlD
Pazopanib—STK10—liver—malaria	0.000131	0.00281	CbGeAlD
Pazopanib—TAOK3—liver—malaria	0.00013	0.00279	CbGeAlD
Pazopanib—PDGFRA—liver—malaria	0.000129	0.00278	CbGeAlD
Pazopanib—PDGFRB—blood—malaria	0.000129	0.00277	CbGeAlD
Pazopanib—KIT—bone marrow—malaria	0.000128	0.00275	CbGeAlD
Pazopanib—Thrombocytopenia—Sulfadiazine—malaria	0.000128	0.00262	CcSEcCtD
Pazopanib—Hepatobiliary disease—Pentoxifylline—malaria	0.000128	0.00261	CcSEcCtD
Pazopanib—Epistaxis—Pentoxifylline—malaria	0.000127	0.0026	CcSEcCtD
Pazopanib—Flushing—Clindamycin—malaria	0.000127	0.0026	CcSEcCtD
Pazopanib—Eye disorder—Quinidine—malaria	0.000126	0.00257	CcSEcCtD
Pazopanib—Eye disorder—Quinine—malaria	0.000126	0.00257	CcSEcCtD
Pazopanib—FGF1—brain—malaria	0.000125	0.00269	CbGeAlD
Pazopanib—Vomiting—Proguanil—malaria	0.000125	0.00256	CcSEcCtD
Pazopanib—PDGFRB—bone marrow—malaria	0.000125	0.00268	CbGeAlD
Pazopanib—Cardiac disorder—Quinine—malaria	0.000125	0.00255	CcSEcCtD
Pazopanib—Cardiac disorder—Quinidine—malaria	0.000125	0.00255	CcSEcCtD
Pazopanib—Flushing—Quinidine—malaria	0.000125	0.00255	CcSEcCtD
Pazopanib—Flushing—Quinine—malaria	0.000125	0.00255	CcSEcCtD
Pazopanib—Anorexia—Sulfadiazine—malaria	0.000125	0.00255	CcSEcCtD
Pazopanib—Rash—Proguanil—malaria	0.000124	0.00254	CcSEcCtD
Pazopanib—Dermatitis—Proguanil—malaria	0.000124	0.00254	CcSEcCtD
Pazopanib—UGT1A1—liver—malaria	0.000123	0.00265	CbGeAlD
Pazopanib—Bradycardia—Quinidine barbiturate—malaria	0.000123	0.00252	CcSEcCtD
Pazopanib—Headache—Proguanil—malaria	0.000123	0.00252	CcSEcCtD
Pazopanib—Erythema—Dapsone—malaria	0.000123	0.00252	CcSEcCtD
Pazopanib—Haemoglobin—Quinidine barbiturate—malaria	0.000122	0.00249	CcSEcCtD
Pazopanib—Haemoglobin—Pentoxifylline—malaria	0.000122	0.00249	CcSEcCtD
Pazopanib—Haemorrhage—Quinidine barbiturate—malaria	0.000121	0.00248	CcSEcCtD
Pazopanib—Mediastinal disorder—Quinidine—malaria	0.000121	0.00248	CcSEcCtD
Pazopanib—Mediastinal disorder—Quinine—malaria	0.000121	0.00248	CcSEcCtD
Pazopanib—Haemorrhage—Pentoxifylline—malaria	0.000121	0.00247	CcSEcCtD
Pazopanib—Chills—Quinine—malaria	0.000121	0.00246	CcSEcCtD
Pazopanib—Chills—Quinidine—malaria	0.000121	0.00246	CcSEcCtD
Pazopanib—Urinary tract disorder—Quinidine barbiturate—malaria	0.00012	0.00245	CcSEcCtD
Pazopanib—Erythema—Clindamycin—malaria	0.000119	0.00244	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000119	0.00243	CcSEcCtD
Pazopanib—Urethral disorder—Quinidine barbiturate—malaria	0.000119	0.00243	CcSEcCtD
Pazopanib—FGFR2—brain—malaria	0.000118	0.00254	CbGeAlD
Pazopanib—Insomnia—Sulfadiazine—malaria	0.000118	0.00242	CcSEcCtD
Pazopanib—Mental disorder—Quinine—malaria	0.000118	0.00241	CcSEcCtD
Pazopanib—Mental disorder—Quinidine—malaria	0.000118	0.00241	CcSEcCtD
Pazopanib—Flatulence—Clindamycin—malaria	0.000118	0.0024	CcSEcCtD
Pazopanib—Malnutrition—Quinine—malaria	0.000117	0.00239	CcSEcCtD
Pazopanib—Malnutrition—Quinidine—malaria	0.000117	0.00239	CcSEcCtD
Pazopanib—Erythema—Quinine—malaria	0.000117	0.00239	CcSEcCtD
Pazopanib—Erythema—Quinidine—malaria	0.000117	0.00239	CcSEcCtD
Pazopanib—Nausea—Proguanil—malaria	0.000117	0.00239	CcSEcCtD
Pazopanib—Dysgeusia—Clindamycin—malaria	0.000117	0.00239	CcSEcCtD
Pazopanib—KDR—liver—malaria	0.000117	0.00251	CbGeAlD
Pazopanib—MAP2K5—liver—malaria	0.000117	0.00251	CbGeAlD
Pazopanib—Vision blurred—Dapsone—malaria	0.000116	0.00237	CcSEcCtD
Pazopanib—ABCG2—saliva-secreting gland—malaria	0.000115	0.00246	CbGeAlD
Pazopanib—Muscle spasms—Clindamycin—malaria	0.000115	0.00234	CcSEcCtD
Pazopanib—CSF1R—liver—malaria	0.000114	0.00244	CbGeAlD
Pazopanib—Decreased appetite—Sulfadiazine—malaria	0.000114	0.00232	CcSEcCtD
Pazopanib—Eye disorder—Quinidine barbiturate—malaria	0.000113	0.00232	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000113	0.00231	CcSEcCtD
Pazopanib—CYP2C8—hematopoietic system—malaria	0.000113	0.00242	CbGeAlD
Pazopanib—Cardiac disorder—Quinidine barbiturate—malaria	0.000113	0.0023	CcSEcCtD
Pazopanib—Flushing—Quinidine barbiturate—malaria	0.000113	0.0023	CcSEcCtD
Pazopanib—Flushing—Pentoxifylline—malaria	0.000112	0.0023	CcSEcCtD
Pazopanib—Vision blurred—Quinine—malaria	0.00011	0.00225	CcSEcCtD
Pazopanib—Vision blurred—Quinidine—malaria	0.00011	0.00225	CcSEcCtD
Pazopanib—Anaemia—Clindamycin—malaria	0.00011	0.00225	CcSEcCtD
Pazopanib—FLT1—brain—malaria	0.00011	0.00235	CbGeAlD
Pazopanib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000109	0.00223	CcSEcCtD
Pazopanib—Chills—Quinidine barbiturate—malaria	0.000109	0.00222	CcSEcCtD
Pazopanib—EPHB6—brain—malaria	0.000108	0.00232	CbGeAlD
Pazopanib—Cough—Dapsone—malaria	0.000108	0.0022	CcSEcCtD
Pazopanib—Gastrointestinal pain—Sulfadiazine—malaria	0.000107	0.00218	CcSEcCtD
Pazopanib—Leukopenia—Clindamycin—malaria	0.000107	0.00218	CcSEcCtD
Pazopanib—Mental disorder—Quinidine barbiturate—malaria	0.000106	0.00217	CcSEcCtD
Pazopanib—Erythema—Quinidine barbiturate—malaria	0.000106	0.00216	CcSEcCtD
Pazopanib—Malnutrition—Quinidine barbiturate—malaria	0.000106	0.00216	CcSEcCtD
Pazopanib—CYP1A2—hematopoietic system—malaria	0.000106	0.00226	CbGeAlD
Pazopanib—Erythema—Pentoxifylline—malaria	0.000105	0.00215	CcSEcCtD
Pazopanib—Syncope—Quinine—malaria	0.000105	0.00214	CcSEcCtD
Pazopanib—Syncope—Quinidine—malaria	0.000105	0.00214	CcSEcCtD
Pazopanib—Leukopenia—Quinidine—malaria	0.000105	0.00214	CcSEcCtD
Pazopanib—Leukopenia—Quinine—malaria	0.000105	0.00214	CcSEcCtD
Pazopanib—Flatulence—Pentoxifylline—malaria	0.000104	0.00212	CcSEcCtD
Pazopanib—STK10—brain—malaria	0.000104	0.00223	CbGeAlD
Pazopanib—KIT—liver—malaria	0.000103	0.00222	CbGeAlD
Pazopanib—TAOK3—brain—malaria	0.000103	0.00222	CbGeAlD
Pazopanib—Abdominal pain—Sulfadiazine—malaria	0.000103	0.00211	CcSEcCtD
Pazopanib—Dysgeusia—Pentoxifylline—malaria	0.000103	0.00211	CcSEcCtD
Pazopanib—Hypertension—Clindamycin—malaria	0.000103	0.0021	CcSEcCtD
Pazopanib—Loss of consciousness—Quinidine—malaria	0.000103	0.0021	CcSEcCtD
Pazopanib—Loss of consciousness—Quinine—malaria	0.000103	0.0021	CcSEcCtD
Pazopanib—SLCO1B1—liver—malaria	0.000103	0.0022	CbGeAlD
Pazopanib—PDGFRA—brain—malaria	0.000103	0.0022	CbGeAlD
Pazopanib—Muscle spasms—Pentoxifylline—malaria	0.000101	0.00207	CcSEcCtD
Pazopanib—PDGFRB—liver—malaria	0.000101	0.00217	CbGeAlD
Pazopanib—Myalgia—Quinidine—malaria	9.96e-05	0.00204	CcSEcCtD
Pazopanib—Chest pain—Quinine—malaria	9.96e-05	0.00204	CcSEcCtD
Pazopanib—Myalgia—Quinine—malaria	9.96e-05	0.00204	CcSEcCtD
Pazopanib—Chest pain—Quinidine—malaria	9.96e-05	0.00204	CcSEcCtD
Pazopanib—Vision blurred—Quinidine barbiturate—malaria	9.95e-05	0.00203	CcSEcCtD
Pazopanib—Vision blurred—Pentoxifylline—malaria	9.93e-05	0.00203	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	9.89e-05	0.00202	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	9.89e-05	0.00202	CcSEcCtD
Pazopanib—ABCB1—blood plasma—malaria	9.78e-05	0.0021	CbGeAlD
Pazopanib—Anaemia—Pentoxifylline—malaria	9.74e-05	0.00199	CcSEcCtD
Pazopanib—Oedema—Quinidine—malaria	9.55e-05	0.00195	CcSEcCtD
Pazopanib—Oedema—Quinine—malaria	9.55e-05	0.00195	CcSEcCtD
Pazopanib—Thrombocytopenia—Clindamycin—malaria	9.53e-05	0.00195	CcSEcCtD
Pazopanib—Syncope—Quinidine barbiturate—malaria	9.47e-05	0.00194	CcSEcCtD
Pazopanib—Leukopenia—Quinidine barbiturate—malaria	9.45e-05	0.00193	CcSEcCtD
Pazopanib—Leukopenia—Pentoxifylline—malaria	9.43e-05	0.00193	CcSEcCtD
Pazopanib—Shock—Quinine—malaria	9.39e-05	0.00192	CcSEcCtD
Pazopanib—Shock—Quinidine—malaria	9.39e-05	0.00192	CcSEcCtD
Pazopanib—Nervous system disorder—Quinidine—malaria	9.36e-05	0.00191	CcSEcCtD
Pazopanib—Nervous system disorder—Quinine—malaria	9.36e-05	0.00191	CcSEcCtD
Pazopanib—Thrombocytopenia—Quinidine—malaria	9.35e-05	0.00191	CcSEcCtD
Pazopanib—Thrombocytopenia—Quinine—malaria	9.35e-05	0.00191	CcSEcCtD
Pazopanib—Loss of consciousness—Quinidine barbiturate—malaria	9.28e-05	0.0019	CcSEcCtD
Pazopanib—Skin disorder—Quinidine—malaria	9.27e-05	0.0019	CcSEcCtD
Pazopanib—Skin disorder—Quinine—malaria	9.27e-05	0.0019	CcSEcCtD
Pazopanib—KDR—brain—malaria	9.27e-05	0.00199	CbGeAlD
Pazopanib—MAP2K5—brain—malaria	9.27e-05	0.00199	CbGeAlD
Pazopanib—Pruritus—Sulfadiazine—malaria	9.25e-05	0.00189	CcSEcCtD
Pazopanib—CYP2C8—kidney—malaria	9.24e-05	0.00198	CbGeAlD
Pazopanib—Hyperhidrosis—Quinidine—malaria	9.23e-05	0.00189	CcSEcCtD
Pazopanib—Hyperhidrosis—Quinine—malaria	9.23e-05	0.00189	CcSEcCtD
Pazopanib—Anorexia—Quinine—malaria	9.1e-05	0.00186	CcSEcCtD
Pazopanib—Anorexia—Quinidine—malaria	9.1e-05	0.00186	CcSEcCtD
Pazopanib—Insomnia—Dapsone—malaria	9.1e-05	0.00186	CcSEcCtD
Pazopanib—Hypertension—Pentoxifylline—malaria	9.1e-05	0.00186	CcSEcCtD
Pazopanib—CSF1R—brain—malaria	9.04e-05	0.00194	CbGeAlD
Pazopanib—Chest pain—Quinidine barbiturate—malaria	8.99e-05	0.00184	CcSEcCtD
Pazopanib—Myalgia—Quinidine barbiturate—malaria	8.99e-05	0.00184	CcSEcCtD
Pazopanib—Arthralgia—Quinidine barbiturate—malaria	8.99e-05	0.00184	CcSEcCtD
Pazopanib—Chest pain—Pentoxifylline—malaria	8.97e-05	0.00183	CcSEcCtD
Pazopanib—Myalgia—Pentoxifylline—malaria	8.97e-05	0.00183	CcSEcCtD
Pazopanib—Diarrhoea—Sulfadiazine—malaria	8.94e-05	0.00183	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	8.93e-05	0.00182	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	8.91e-05	0.00182	CcSEcCtD
Pazopanib—Dry mouth—Pentoxifylline—malaria	8.78e-05	0.00179	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Quinine—malaria	8.7e-05	0.00178	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Quinidine—malaria	8.7e-05	0.00178	CcSEcCtD
Pazopanib—Dyspnoea—Clindamycin—malaria	8.68e-05	0.00177	CcSEcCtD
Pazopanib—Oedema—Quinidine barbiturate—malaria	8.62e-05	0.00176	CcSEcCtD
Pazopanib—Oedema—Pentoxifylline—malaria	8.6e-05	0.00176	CcSEcCtD
Pazopanib—Dyspepsia—Clindamycin—malaria	8.57e-05	0.00175	CcSEcCtD
Pazopanib—Infection—Pentoxifylline—malaria	8.55e-05	0.00175	CcSEcCtD
Pazopanib—Dyspnoea—Quinidine—malaria	8.51e-05	0.00174	CcSEcCtD
Pazopanib—Dyspnoea—Quinine—malaria	8.51e-05	0.00174	CcSEcCtD
Pazopanib—Shock—Quinidine barbiturate—malaria	8.48e-05	0.00173	CcSEcCtD
Pazopanib—Shock—Pentoxifylline—malaria	8.46e-05	0.00173	CcSEcCtD
Pazopanib—Nervous system disorder—Quinidine barbiturate—malaria	8.45e-05	0.00173	CcSEcCtD
Pazopanib—Thrombocytopenia—Quinidine barbiturate—malaria	8.44e-05	0.00172	CcSEcCtD
Pazopanib—Thrombocytopenia—Pentoxifylline—malaria	8.42e-05	0.00172	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Clindamycin—malaria	8.4e-05	0.00172	CcSEcCtD
Pazopanib—Fatigue—Clindamycin—malaria	8.39e-05	0.00171	CcSEcCtD
Pazopanib—Skin disorder—Quinidine barbiturate—malaria	8.37e-05	0.00171	CcSEcCtD
Pazopanib—Skin disorder—Pentoxifylline—malaria	8.36e-05	0.00171	CcSEcCtD
Pazopanib—Hyperhidrosis—Quinidine barbiturate—malaria	8.33e-05	0.0017	CcSEcCtD
Pazopanib—Pain—Clindamycin—malaria	8.32e-05	0.0017	CcSEcCtD
Pazopanib—Hyperhidrosis—Pentoxifylline—malaria	8.32e-05	0.0017	CcSEcCtD
Pazopanib—Vomiting—Sulfadiazine—malaria	8.31e-05	0.0017	CcSEcCtD
Pazopanib—Decreased appetite—Quinidine—malaria	8.3e-05	0.0017	CcSEcCtD
Pazopanib—Decreased appetite—Quinine—malaria	8.3e-05	0.0017	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Quinidine—malaria	8.24e-05	0.00168	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Quinine—malaria	8.24e-05	0.00168	CcSEcCtD
Pazopanib—Rash—Sulfadiazine—malaria	8.24e-05	0.00168	CcSEcCtD
Pazopanib—Dermatitis—Sulfadiazine—malaria	8.23e-05	0.00168	CcSEcCtD
Pazopanib—Gastrointestinal pain—Dapsone—malaria	8.23e-05	0.00168	CcSEcCtD
Pazopanib—Anorexia—Quinidine barbiturate—malaria	8.21e-05	0.00168	CcSEcCtD
Pazopanib—KIT—brain—malaria	8.21e-05	0.00176	CbGeAlD
Pazopanib—Anorexia—Pentoxifylline—malaria	8.2e-05	0.00168	CcSEcCtD
Pazopanib—Headache—Sulfadiazine—malaria	8.19e-05	0.00167	CcSEcCtD
Pazopanib—PDGFRB—brain—malaria	8.02e-05	0.00172	CbGeAlD
Pazopanib—Gastrointestinal pain—Clindamycin—malaria	7.96e-05	0.00163	CcSEcCtD
Pazopanib—Abdominal pain—Dapsone—malaria	7.95e-05	0.00163	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	7.85e-05	0.0016	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Pentoxifylline—malaria	7.84e-05	0.0016	CcSEcCtD
Pazopanib—Gastrointestinal pain—Quinidine—malaria	7.81e-05	0.0016	CcSEcCtD
Pazopanib—Gastrointestinal pain—Quinine—malaria	7.81e-05	0.0016	CcSEcCtD
Pazopanib—Insomnia—Pentoxifylline—malaria	7.78e-05	0.00159	CcSEcCtD
Pazopanib—Nausea—Sulfadiazine—malaria	7.76e-05	0.00159	CcSEcCtD
Pazopanib—Abdominal pain—Clindamycin—malaria	7.69e-05	0.00157	CcSEcCtD
Pazopanib—Dyspnoea—Quinidine barbiturate—malaria	7.68e-05	0.00157	CcSEcCtD
Pazopanib—Dyspnoea—Pentoxifylline—malaria	7.67e-05	0.00157	CcSEcCtD
Pazopanib—Somnolence—Quinidine barbiturate—malaria	7.66e-05	0.00157	CcSEcCtD
Pazopanib—Somnolence—Pentoxifylline—malaria	7.65e-05	0.00156	CcSEcCtD
Pazopanib—CYP3A4—hematopoietic system—malaria	7.64e-05	0.00164	CbGeAlD
Pazopanib—Dyspepsia—Pentoxifylline—malaria	7.57e-05	0.00155	CcSEcCtD
Pazopanib—Abdominal pain—Quinine—malaria	7.55e-05	0.00154	CcSEcCtD
Pazopanib—Abdominal pain—Quinidine—malaria	7.55e-05	0.00154	CcSEcCtD
Pazopanib—CYP2D6—hematopoietic system—malaria	7.52e-05	0.00161	CbGeAlD
Pazopanib—Decreased appetite—Quinidine barbiturate—malaria	7.49e-05	0.00153	CcSEcCtD
Pazopanib—Decreased appetite—Pentoxifylline—malaria	7.48e-05	0.00153	CcSEcCtD
Pazopanib—CYP2C8—blood—malaria	7.47e-05	0.0016	CbGeAlD
Pazopanib—Gastrointestinal disorder—Quinidine barbiturate—malaria	7.44e-05	0.00152	CcSEcCtD
Pazopanib—Pain—Quinidine barbiturate—malaria	7.37e-05	0.00151	CcSEcCtD
Pazopanib—CYP1A2—digestive system—malaria	7.34e-05	0.00157	CbGeAlD
Pazopanib—ABCG2—blood—malaria	7.26e-05	0.00156	CbGeAlD
Pazopanib—Gastrointestinal pain—Quinidine barbiturate—malaria	7.05e-05	0.00144	CcSEcCtD
Pazopanib—Gastrointestinal pain—Pentoxifylline—malaria	7.03e-05	0.00144	CcSEcCtD
Pazopanib—ABCG2—bone marrow—malaria	7.03e-05	0.00151	CbGeAlD
Pazopanib—CYP1A2—blood—malaria	6.99e-05	0.0015	CbGeAlD
Pazopanib—Asthenia—Clindamycin—malaria	6.98e-05	0.00143	CcSEcCtD
Pazopanib—Pruritus—Clindamycin—malaria	6.89e-05	0.00141	CcSEcCtD
Pazopanib—Asthenia—Quinine—malaria	6.85e-05	0.0014	CcSEcCtD
Pazopanib—Asthenia—Quinidine—malaria	6.85e-05	0.0014	CcSEcCtD
Pazopanib—Abdominal pain—Quinidine barbiturate—malaria	6.81e-05	0.00139	CcSEcCtD
Pazopanib—Abdominal pain—Pentoxifylline—malaria	6.8e-05	0.00139	CcSEcCtD
Pazopanib—Pruritus—Quinine—malaria	6.76e-05	0.00138	CcSEcCtD
Pazopanib—Pruritus—Quinidine—malaria	6.76e-05	0.00138	CcSEcCtD
Pazopanib—Diarrhoea—Clindamycin—malaria	6.66e-05	0.00136	CcSEcCtD
Pazopanib—Diarrhoea—Quinidine—malaria	6.53e-05	0.00134	CcSEcCtD
Pazopanib—Diarrhoea—Quinine—malaria	6.53e-05	0.00134	CcSEcCtD
Pazopanib—Dizziness—Clindamycin—malaria	6.44e-05	0.00132	CcSEcCtD
Pazopanib—Vomiting—Dapsone—malaria	6.4e-05	0.00131	CcSEcCtD
Pazopanib—Dizziness—Quinidine—malaria	6.31e-05	0.00129	CcSEcCtD
Pazopanib—Dizziness—Quinine—malaria	6.31e-05	0.00129	CcSEcCtD
Pazopanib—Headache—Dapsone—malaria	6.3e-05	0.00129	CcSEcCtD
Pazopanib—CYP3A4—kidney—malaria	6.26e-05	0.00134	CbGeAlD
Pazopanib—Vomiting—Clindamycin—malaria	6.19e-05	0.00126	CcSEcCtD
Pazopanib—Asthenia—Quinidine barbiturate—malaria	6.18e-05	0.00126	CcSEcCtD
Pazopanib—Asthenia—Pentoxifylline—malaria	6.17e-05	0.00126	CcSEcCtD
Pazopanib—CYP2D6—kidney—malaria	6.16e-05	0.00132	CbGeAlD
Pazopanib—Rash—Clindamycin—malaria	6.14e-05	0.00125	CcSEcCtD
Pazopanib—Dermatitis—Clindamycin—malaria	6.13e-05	0.00125	CcSEcCtD
Pazopanib—Headache—Clindamycin—malaria	6.1e-05	0.00125	CcSEcCtD
Pazopanib—Pruritus—Quinidine barbiturate—malaria	6.1e-05	0.00125	CcSEcCtD
Pazopanib—Pruritus—Pentoxifylline—malaria	6.09e-05	0.00124	CcSEcCtD
Pazopanib—Vomiting—Quinidine—malaria	6.07e-05	0.00124	CcSEcCtD
Pazopanib—Vomiting—Quinine—malaria	6.07e-05	0.00124	CcSEcCtD
Pazopanib—Rash—Quinine—malaria	6.02e-05	0.00123	CcSEcCtD
Pazopanib—Rash—Quinidine—malaria	6.02e-05	0.00123	CcSEcCtD
Pazopanib—Dermatitis—Quinine—malaria	6.01e-05	0.00123	CcSEcCtD
Pazopanib—Dermatitis—Quinidine—malaria	6.01e-05	0.00123	CcSEcCtD
Pazopanib—Headache—Quinidine—malaria	5.98e-05	0.00122	CcSEcCtD
Pazopanib—Headache—Quinine—malaria	5.98e-05	0.00122	CcSEcCtD
Pazopanib—Nausea—Dapsone—malaria	5.98e-05	0.00122	CcSEcCtD
Pazopanib—Diarrhoea—Quinidine barbiturate—malaria	5.9e-05	0.0012	CcSEcCtD
Pazopanib—Diarrhoea—Pentoxifylline—malaria	5.89e-05	0.0012	CcSEcCtD
Pazopanib—CYP2C8—liver—malaria	5.84e-05	0.00125	CbGeAlD
Pazopanib—Nausea—Clindamycin—malaria	5.78e-05	0.00118	CcSEcCtD
Pazopanib—Dizziness—Quinidine barbiturate—malaria	5.7e-05	0.00116	CcSEcCtD
Pazopanib—Dizziness—Pentoxifylline—malaria	5.69e-05	0.00116	CcSEcCtD
Pazopanib—ABCG2—liver—malaria	5.68e-05	0.00122	CbGeAlD
Pazopanib—Nausea—Quinidine—malaria	5.67e-05	0.00116	CcSEcCtD
Pazopanib—Nausea—Quinine—malaria	5.67e-05	0.00116	CcSEcCtD
Pazopanib—Vomiting—Quinidine barbiturate—malaria	5.48e-05	0.00112	CcSEcCtD
Pazopanib—Vomiting—Pentoxifylline—malaria	5.47e-05	0.00112	CcSEcCtD
Pazopanib—CYP1A2—liver—malaria	5.47e-05	0.00117	CbGeAlD
Pazopanib—Rash—Quinidine barbiturate—malaria	5.43e-05	0.00111	CcSEcCtD
Pazopanib—Dermatitis—Quinidine barbiturate—malaria	5.43e-05	0.00111	CcSEcCtD
Pazopanib—Rash—Pentoxifylline—malaria	5.42e-05	0.00111	CcSEcCtD
Pazopanib—Dermatitis—Pentoxifylline—malaria	5.42e-05	0.00111	CcSEcCtD
Pazopanib—ABCB1—hematopoietic system—malaria	5.41e-05	0.00116	CbGeAlD
Pazopanib—Headache—Quinidine barbiturate—malaria	5.4e-05	0.0011	CcSEcCtD
Pazopanib—Headache—Pentoxifylline—malaria	5.39e-05	0.0011	CcSEcCtD
Pazopanib—CYP3A4—digestive system—malaria	5.31e-05	0.00114	CbGeAlD
Pazopanib—CYP2D6—digestive system—malaria	5.23e-05	0.00112	CbGeAlD
Pazopanib—Nausea—Quinidine barbiturate—malaria	5.12e-05	0.00105	CcSEcCtD
Pazopanib—Nausea—Pentoxifylline—malaria	5.11e-05	0.00104	CcSEcCtD
Pazopanib—CYP3A4—blood—malaria	5.06e-05	0.00109	CbGeAlD
Pazopanib—CYP2D6—blood—malaria	4.98e-05	0.00107	CbGeAlD
Pazopanib—CYP2C8—brain—malaria	4.64e-05	0.000995	CbGeAlD
Pazopanib—ABCG2—brain—malaria	4.51e-05	0.000967	CbGeAlD
Pazopanib—ABCB1—kidney—malaria	4.43e-05	0.000951	CbGeAlD
Pazopanib—CYP3A4—liver—malaria	3.96e-05	0.000849	CbGeAlD
Pazopanib—CYP2D6—liver—malaria	3.89e-05	0.000835	CbGeAlD
Pazopanib—ABCB1—digestive system—malaria	3.76e-05	0.000807	CbGeAlD
Pazopanib—ABCB1—blood—malaria	3.58e-05	0.000768	CbGeAlD
Pazopanib—ABCB1—bone marrow—malaria	3.47e-05	0.000744	CbGeAlD
Pazopanib—CYP2D6—brain—malaria	3.09e-05	0.000663	CbGeAlD
Pazopanib—ABCB1—liver—malaria	2.8e-05	0.000601	CbGeAlD
Pazopanib—ABCB1—brain—malaria	2.22e-05	0.000477	CbGeAlD
Pazopanib—LCK—Fc epsilon receptor (FCERI) signaling—IL6—malaria	6.41e-06	0.000195	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—CD4—malaria	6.38e-06	0.000194	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—IL6—malaria	6.38e-06	0.000194	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—CD4—malaria	6.37e-06	0.000194	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR—IL6—malaria	6.35e-06	0.000193	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR in Cancer—IL6—malaria	6.29e-06	0.000192	CbGpPWpGaD
Pazopanib—LCK—Signaling by PDGF—IL6—malaria	6.27e-06	0.000191	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—DHFR—malaria	6.26e-06	0.000191	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HLA-B—malaria	6.23e-06	0.00019	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HLA-B—malaria	6.21e-06	0.000189	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—SCARB1—malaria	6.19e-06	0.000189	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—HPGDS—malaria	6.18e-06	0.000188	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TLR9—malaria	6.18e-06	0.000188	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—CD4—malaria	6.13e-06	0.000187	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—CD4—malaria	6.11e-06	0.000186	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD36—malaria	6.11e-06	0.000186	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD36—malaria	6.09e-06	0.000186	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—IL2—malaria	6.06e-06	0.000184	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—IL6—malaria	6.05e-06	0.000184	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—IL6—malaria	6.04e-06	0.000184	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—ICAM1—malaria	6.02e-06	0.000183	CbGpPWpGaD
Pazopanib—FGF1—Disease—NOS2—malaria	6.01e-06	0.000183	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SLC4A1—malaria	6.01e-06	0.000183	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IFNG—malaria	6.01e-06	0.000183	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL18—malaria	5.91e-06	0.00018	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CRP—malaria	5.91e-06	0.00018	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD40LG—malaria	5.88e-06	0.000179	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—HBB—malaria	5.86e-06	0.000179	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD8A—malaria	5.82e-06	0.000177	CbGpPWpGaD
Pazopanib—KIT—Immune System—CRP—malaria	5.8e-06	0.000177	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CD4—malaria	5.8e-06	0.000177	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL18—malaria	5.78e-06	0.000176	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD40LG—malaria	5.76e-06	0.000175	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—IL2—malaria	5.74e-06	0.000175	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—CD4—malaria	5.74e-06	0.000175	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—DHFR—malaria	5.74e-06	0.000175	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—HPGDS—malaria	5.72e-06	0.000174	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD8A—malaria	5.7e-06	0.000174	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—SCARB1—malaria	5.68e-06	0.000173	CbGpPWpGaD
Pazopanib—LCK—NGF signalling via TRKA from the plasma membrane—IL6—malaria	5.68e-06	0.000173	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—TLR4—malaria	5.66e-06	0.000173	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SLC4A1—malaria	5.66e-06	0.000172	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—DECR1—malaria	5.65e-06	0.000172	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—DHODH—malaria	5.64e-06	0.000172	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—CD4—malaria	5.62e-06	0.000171	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—IL6—malaria	5.61e-06	0.000171	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HLA-B—malaria	5.6e-06	0.00017	CbGpPWpGaD
Pazopanib—ITK—Immune System—IL6—malaria	5.6e-06	0.00017	CbGpPWpGaD
Pazopanib—KIT—Immune System—TLR4—malaria	5.56e-06	0.000169	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	5.55e-06	0.000169	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD4—malaria	5.51e-06	0.000168	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CRP—malaria	5.51e-06	0.000168	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CRP—malaria	5.49e-06	0.000167	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD36—malaria	5.49e-06	0.000167	CbGpPWpGaD
Pazopanib—LYN—Immune System—HLA-B—malaria	5.48e-06	0.000167	CbGpPWpGaD
Pazopanib—FGFR1—Axon guidance—IL6—malaria	5.48e-06	0.000167	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—IL6—malaria	5.44e-06	0.000166	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—ICAM1—malaria	5.43e-06	0.000165	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—IL6—malaria	5.42e-06	0.000165	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD4—malaria	5.39e-06	0.000164	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—IL6—malaria	5.39e-06	0.000164	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD36—malaria	5.37e-06	0.000164	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL1B—malaria	5.36e-06	0.000163	CbGpPWpGaD
Pazopanib—FGFR3—Disease—CD4—malaria	5.36e-06	0.000163	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL2—malaria	5.34e-06	0.000163	CbGpPWpGaD
Pazopanib—KIT—Immune System—ICAM1—malaria	5.33e-06	0.000162	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—DECR1—malaria	5.32e-06	0.000162	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—KDR—malaria	5.32e-06	0.000162	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—IL6—malaria	5.31e-06	0.000162	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—DHFR—malaria	5.31e-06	0.000162	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—TLR4—malaria	5.28e-06	0.000161	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—TLR4—malaria	5.26e-06	0.00016	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—SCARB1—malaria	5.26e-06	0.00016	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PKLR—malaria	5.23e-06	0.000159	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—HBB—malaria	5.11e-06	0.000156	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	5.09e-06	0.000155	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—ICAM1—malaria	5.06e-06	0.000154	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—ICAM1—malaria	5.05e-06	0.000154	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IFNG—malaria	4.99e-06	0.000152	CbGpPWpGaD
Pazopanib—FGFR2—Disease—NOS2—malaria	4.97e-06	0.000151	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CRP—malaria	4.95e-06	0.000151	CbGpPWpGaD
Pazopanib—KIT—Disease—NOS2—malaria	4.88e-06	0.000149	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—TNF—malaria	4.84e-06	0.000148	CbGpPWpGaD
Pazopanib—LYN—Immune System—CRP—malaria	4.84e-06	0.000148	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD4—malaria	4.82e-06	0.000147	CbGpPWpGaD
Pazopanib—LYN—Axon guidance—IL6—malaria	4.82e-06	0.000147	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—HBB—malaria	4.81e-06	0.000147	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SLC4A1—malaria	4.8e-06	0.000146	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—KDR—malaria	4.76e-06	0.000145	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—TLR4—malaria	4.74e-06	0.000144	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL18—malaria	4.74e-06	0.000144	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD40LG—malaria	4.72e-06	0.000144	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—IL2—malaria	4.71e-06	0.000143	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD8A—malaria	4.67e-06	0.000142	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—G6PD—malaria	4.66e-06	0.000142	CbGpPWpGaD
Pazopanib—LYN—Immune System—TLR4—malaria	4.64e-06	0.000141	CbGpPWpGaD
Pazopanib—FGFR1—Disease—NOS2—malaria	4.63e-06	0.000141	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—NOS2—malaria	4.62e-06	0.000141	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—CD4—malaria	4.6e-06	0.00014	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	4.6e-06	0.00014	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PKLR—malaria	4.55e-06	0.000139	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—ICAM1—malaria	4.55e-06	0.000139	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL2—malaria	4.52e-06	0.000138	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—DECR1—malaria	4.51e-06	0.000137	CbGpPWpGaD
Pazopanib—LCK—Immune System—HLA-B—malaria	4.49e-06	0.000137	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—IL6—malaria	4.48e-06	0.000136	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL1B—malaria	4.45e-06	0.000136	CbGpPWpGaD
Pazopanib—LYN—Immune System—ICAM1—malaria	4.45e-06	0.000136	CbGpPWpGaD
Pazopanib—FGF1—Disease—CD4—malaria	4.45e-06	0.000136	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—IL6—malaria	4.44e-06	0.000135	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL2—malaria	4.44e-06	0.000135	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—KDR—malaria	4.42e-06	0.000135	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD4—malaria	4.42e-06	0.000135	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD36—malaria	4.4e-06	0.000134	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—IL6—malaria	4.37e-06	0.000133	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DHODH—malaria	4.35e-06	0.000133	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PKLR—malaria	4.29e-06	0.000131	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—TNF—malaria	4.26e-06	0.00013	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—NOS2—malaria	4.16e-06	0.000127	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IFNG—malaria	4.13e-06	0.000126	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—HBB—malaria	4.08e-06	0.000124	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—G6PD—malaria	4.06e-06	0.000124	CbGpPWpGaD
Pazopanib—KIT—Immune System—IFNG—malaria	4.06e-06	0.000124	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD4—malaria	3.99e-06	0.000122	CbGpPWpGaD
Pazopanib—LCK—Immune System—CRP—malaria	3.97e-06	0.000121	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD4—malaria	3.92e-06	0.000119	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	3.91e-06	0.000119	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—IL6—malaria	3.91e-06	0.000119	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—IL6—malaria	3.89e-06	0.000119	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CD36—malaria	3.89e-06	0.000118	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IFNG—malaria	3.85e-06	0.000117	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IFNG—malaria	3.84e-06	0.000117	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—G6PD—malaria	3.82e-06	0.000117	CbGpPWpGaD
Pazopanib—LCK—Immune System—TLR4—malaria	3.81e-06	0.000116	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD4—malaria	3.72e-06	0.000113	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD4—malaria	3.71e-06	0.000113	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—IL6—malaria	3.7e-06	0.000113	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SLC4A1—malaria	3.7e-06	0.000113	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL1B—malaria	3.68e-06	0.000112	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CD4—malaria	3.68e-06	0.000112	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL2—malaria	3.67e-06	0.000112	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—KDR—malaria	3.66e-06	0.000112	CbGpPWpGaD
Pazopanib—LCK—Immune System—ICAM1—malaria	3.65e-06	0.000111	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—IL6—malaria	3.64e-06	0.000111	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PKLR—malaria	3.63e-06	0.000111	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL1B—malaria	3.62e-06	0.00011	CbGpPWpGaD
Pazopanib—KIT—Disease—CD4—malaria	3.62e-06	0.00011	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL2—malaria	3.61e-06	0.00011	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—KDR—malaria	3.6e-06	0.00011	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CD36—malaria	3.56e-06	0.000109	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—IL6—malaria	3.56e-06	0.000108	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—HPGDS—malaria	3.55e-06	0.000108	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DECR1—malaria	3.48e-06	0.000106	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IFNG—malaria	3.46e-06	0.000105	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—IL6—malaria	3.45e-06	0.000105	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL2—malaria	3.45e-06	0.000105	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—IL6—malaria	3.44e-06	0.000105	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—IL6—malaria	3.44e-06	0.000105	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL1B—malaria	3.43e-06	0.000105	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CD4—malaria	3.43e-06	0.000105	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL1B—malaria	3.43e-06	0.000104	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CD4—malaria	3.42e-06	0.000104	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL2—malaria	3.42e-06	0.000104	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL2—malaria	3.41e-06	0.000104	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—KDR—malaria	3.41e-06	0.000104	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—KDR—malaria	3.4e-06	0.000104	CbGpPWpGaD
Pazopanib—LYN—Immune System—IFNG—malaria	3.39e-06	0.000103	CbGpPWpGaD
Pazopanib—LCK—Disease—NOS2—malaria	3.34e-06	0.000102	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD4—malaria	3.34e-06	0.000102	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CD36—malaria	3.3e-06	0.0001	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—DHFR—malaria	3.3e-06	0.0001	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD4—malaria	3.27e-06	9.97e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—SCARB1—malaria	3.26e-06	9.94e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—G6PD—malaria	3.24e-06	9.87e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	3.2e-06	9.74e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—HBB—malaria	3.15e-06	9.59e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL6—malaria	3.14e-06	9.56e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—IL6—malaria	3.1e-06	9.45e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—HPGDS—malaria	3.1e-06	9.43e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL1B—malaria	3.09e-06	9.4e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD4—malaria	3.09e-06	9.4e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL2—malaria	3.08e-06	9.4e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL2—malaria	3.07e-06	9.37e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—KDR—malaria	3.07e-06	9.34e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—IL6—malaria	3.04e-06	9.25e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL1B—malaria	3.02e-06	9.2e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL2—malaria	3.01e-06	9.17e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL2—malaria	3.01e-06	9.16e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—KDR—malaria	3e-06	9.15e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—HPGDS—malaria	2.92e-06	8.89e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—IL6—malaria	2.9e-06	8.82e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—DHFR—malaria	2.87e-06	8.75e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2—malaria	2.87e-06	8.74e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SCARB1—malaria	2.84e-06	8.66e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PKLR—malaria	2.81e-06	8.55e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFNG—malaria	2.78e-06	8.46e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—DHFR—malaria	2.71e-06	8.24e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD4—malaria	2.68e-06	8.17e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SCARB1—malaria	2.68e-06	8.16e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL6—malaria	2.66e-06	8.09e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL6—malaria	2.61e-06	7.94e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—G6PD—malaria	2.5e-06	7.62e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—IL6—malaria	2.49e-06	7.59e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—malaria	2.48e-06	7.54e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—malaria	2.48e-06	7.54e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—HPGDS—malaria	2.47e-06	7.53e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—malaria	2.47e-06	7.52e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—KDR—malaria	2.46e-06	7.5e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—IL6—malaria	2.41e-06	7.33e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—malaria	2.37e-06	7.23e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—malaria	2.33e-06	7.1e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—DHFR—malaria	2.29e-06	6.98e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SCARB1—malaria	2.27e-06	6.91e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—malaria	2.21e-06	6.74e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—malaria	2.21e-06	6.72e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL6—malaria	2.16e-06	6.57e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—malaria	2.12e-06	6.46e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CD36—malaria	2.05e-06	6.24e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—malaria	2.03e-06	6.18e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—malaria	2.01e-06	6.13e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—malaria	2.01e-06	6.11e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—malaria	1.99e-06	6.07e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—malaria	1.99e-06	6.06e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—malaria	1.96e-06	5.96e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—malaria	1.95e-06	5.93e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—HPGDS—malaria	1.91e-06	5.81e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—malaria	1.86e-06	5.66e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—malaria	1.85e-06	5.64e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—malaria	1.81e-06	5.52e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—malaria	1.81e-06	5.51e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CD36—malaria	1.78e-06	5.43e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—malaria	1.77e-06	5.39e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DHFR—malaria	1.77e-06	5.39e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—malaria	1.77e-06	5.38e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SCARB1—malaria	1.75e-06	5.33e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—malaria	1.69e-06	5.13e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CD36—malaria	1.68e-06	5.12e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—malaria	1.67e-06	5.08e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—malaria	1.6e-06	4.86e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—malaria	1.45e-06	4.42e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CD36—malaria	1.42e-06	4.34e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—malaria	1.39e-06	4.25e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—malaria	1.37e-06	4.17e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—malaria	1.34e-06	4.08e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—malaria	1.3e-06	3.96e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—malaria	1.3e-06	3.95e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—malaria	1.17e-06	3.56e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—malaria	1.14e-06	3.48e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CD36—malaria	1.1e-06	3.35e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—malaria	9.38e-07	2.86e-05	CbGpPWpGaD
